comparemela.com
  1. Home
  2. Live Updates
  3. Fred Saad - Breaking News

Latest Breaking News On - Fred saad - Page 3 : comparemela.com

PROfound: Phase 3 Study of Olaparib vs Enzalutamide or Abiraterone for Metastatic Castration-Resistant Prostate Cancer with Homologous Recombination Repair Gene Alterations

PROfound: Phase 3 Study of Olaparib vs Enzalutamide or Abiraterone for Metastatic Castration-Resistant Prostate Cancer with Homologous Recombination Repair Gene Alterations
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoNobuaki matsubaraMaha ha hussainFred saadAntoine thiery vuilleminKim chiKarim fizaziJoaquin mateoSelena castroKimn chiOlaparib lynparzaEuropean multidisciplinary congress on urological cancersAmerican urologic associationVirtual annual meetingJohann de bono

ASCO GU 2023: Efficacy and Safety of Darolutamide in Combination with ADT and Docetaxel by Disease Volume and Disease Risk in the Phase 3 ARASENS Study

ASCO GU 2023: Efficacy and Safety of Darolutamide in Combination with ADT and Docetaxel by Disease Volume and Disease Risk in the Phase 3 ARASENS Study
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United statesNorthwestern universitySan franciscoMaha ha hussainFred saadMartin boegemannKarim fizaziMaha hussainFrank verholenShankar srinivasanBertrandf tombalIris kussShivani kapurHeikki joensuuArash rezazadehE david crawford

Physical activity may slow cancer growth: Montreal study

Proteins produced by muscles during physical activity could inhibit the development of prostate cancer cells and thus slow the progression of the disease, suggests a study involving a Montreal researcher.

Rob newtonFred saadAustralia edith cowan universityEdith cowan universityProfessor rob newtonProstate cancer

Olaparib Prolongs rPFS in Metastatic Castration-Resistant Prostate Cancer

Adding olaparib to first-line abiraterone improved radiographic progression-free survival in metastatic castration-resistant prostate cancer.

Fred saadUniversity of montreal hospital centerMerck sharp dohme corpMontreal hospital centerCancers symposiumMerck sharp

Olaparib Prolongs rPFS in Metastatic Castration-Resistant Prostate Cancer

Adding olaparib to first-line abiraterone improved radiographic progression-free survival in metastatic castration-resistant prostate cancer.

Fred saadUniversity of montreal hospital centerMerck sharp dohme corpCancers symposiumCancer therapy advisorMontreal hospital centerMerck sharp

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.